Model for predicting the risk of severe bronchial asthma in children

ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS | ORIGINAL ARTICLE

Volume 71 • Issue 4 • Desember 2022, pp. 28-35

Received: 19.08.2022​ | Accepted for publication: 07.11.2022 | ​Publication date: 20.12.2022

ORCID logo O.E. Semernik , ORCID logo A.A. Lebedenko , ORCID logo E.B. Tyurina , ORCID logo M.V. Dudareva 

Rostov State Medical University, 344022, Rostov-on-Don, Nakchichevan lane, Russia

Full text PDF (rus)
Abstract

Objective: to develop a model for predicting the severe course of bronchial asthma (BA) in children.

Materials and methods: a comprehensive examination was conducted of 213 children aged 3 to 12 years suffering from atopic asthma (mild course was observed in 85.0%, moderate — in 10.3%, severe — 4.7%). A statistical analysis of clinical and laboratory parameters was performed using the logistic regression method, which allowed us to identify a number of factors that increase the probability of developing a more severe course of BA in children.

Results. A mathematical model for predicting the risk of severe bronchial asthma in children has been developed, including such factors as the child’s age, the degree of respiratory failure, the value of the peak expiratory rate, the duration of the disease, and the presence of an association of exacerbations of the disease with changes in the weather and physical activity. A computer program has also been developed that allows you to automatically calculate the amount of risk after entering the child’s data.

Conclusion. The use of this model makes it possible to predict the further course of BA with a high degree of confidence, and, consequently, to correct the basic therapy in time to prevent the development of complications in a sick child.

References

1. Aw M, Penn J, Gauvreau GM, Lima H, Sehmi R. Atopic March: Collegium Internationale Allergologicum Update 2020. Int. Arch. Allergy Immunol. 2020; 181 (1): 1–10. https://doi.org/10.1159/000502958.

2. Odhiambo JA, Williams HC, Clayton TO et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009; 124 (6): 1251–1258: e23. https://doi.org/10.1016/j.jaci.2009.10.009.

3. Williams H, Stewart A, Mutius E von, Cookson W, Anderson HR. International Study of Asthma and Allergies in Childhood (ISAAC). Phase One and Three Study Groups. Is eczema really on the increase worldwide? J Allergy Clin Immunol. 2008; 121 (4): 947–954: e15. https://doi.org/10.1016/j.jaci.2007.11.0044.

4. Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика». 5-е изд., перераб. и доп. М.: Оригинал-макет. 2017: 160. [Nacional’naya programma «Bronhial’naya astma u detej. Strategiya lecheniya i profilaktika». 5-e izd., pererab. i dop. M.: Original-maket. 2017: 160. (In Russ.)]

5. 2020 GINA Report, Global Strategy for Asthma Management and Prevention. GINA, 2020: 211. URL: https://ginasthma.org/gina-reports/ (23.06.2020).

6. Мизерницкий ЮЛ, Цыпленкова СЭ. Клиническое значение и современные возможности мониторирования уровня оксида азота в выдыхаемом воздухе в детской пульмонологической практике. Пульмонология детского возраста: проблемы и решения. М: «Медпрактика-М», 2014; 14: 9–15. [Mizernitskiy YL, Cyplenkova SE. Klinicheskoe znachenie i sovremennye vozmozhnosti monitorirovaniya urovnya oksida azota v vydyhaemom vozduhe v detskoj pul’monologicheskoj praktike. Pul’monologiya detskogo vozrasta: problemy i resheniya. M: «Medpraktika-M», 2014; 14: 9–15. (In Russ.)]

7. Wildfire JJ, Gergen PJ, Sorkness ChA et al. Development and validation of the Composite Asthma Severity Index — an outcome measure for use in children and adolescents. J Allergy Clin Immunol. 2012; 129 (3): 694–701. https://doi.org/10.1016/j.jaci.2011.12.962.

8. Jean T, Yang S-J, Crawford WW, Takahashi SH, Sheikh J. Development of a pediatric asthma predictive index for hospitalization. Ann Allergy Asthma Immunol. 2019; 122 (3): 283–288. https://doi.org/10.1016/j.anai.2018.11.021.

9. Жданович ЕА, Фурман ЕГ, Карпова ИА, Палкин СБ. Биомаркеры, функция внешнего дыхания и клиническое течение бронхолегочной дисплазии. Российский вестник перинатологии и педиатрии. 2016; 61 (4): 70–76. https://doi.org/10.21508/1027-4065-2016-61-4-70-76. [Zhdanovich EA, Furman EG, Karpova IA, Palkin SB. Biomarkery, funkciya vneshnego dyhaniya i klinicheskoe techenie bronholegochnoj displazii. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2016; 61 (4): 70–76. (In Russ.)] https://doi.org/10.21508/1027-4065-2016-61-4-70-76.

10. Banasiak NC. Implementation of the Asthma Control Test in Primary Care to Improve Patient Outcomes. J Pediatr Health Care. 2018; 32 (6): 591–599. DOI: 10.1016/j.pedhc.2018.05.004.

11. Wandalsen GF, Dias RG, Chong-Neto HJ et al. Test for Respiratory and Asthma Control in Kids (TRACK): validation of the Portuguese version. World Allergy Organ J. 2018; 11(1): 40. https://doi.org/10.1186/s40413-018-0219-y.

Citation

Semernik OE, Lebedenko AA, Tyurina EB, Dudareva MV. A model for predicting the risk of developing severe bronchial asthma in children. Allergology and Immunology in Pediatrics. 2022; 4: 28–35. (In Russ.) https://doi.org/10.53529/2500-1175-2022-4-28-35

For correspondence:

Olga E. Semernik

MD, Associate Professor of the Department of Children’s Diseases № 2 of Rostov State Medical University

ORCID logo   0000-0002-3769-8014
map marker alt icon   344022, Rostov-on-Don, Nakchichevan lane, Russia
smt1 email icon   semernick@mail.ru

Supporting agencies:

There is no source of funding

Сonflict of interest::

no conflict of interest

ALLERGOLOGY and IMMUNOLOGY in PEDIATRICS